ESP Versus TEA for Oeasophagus Cancer Surgery

Launched by VINMEC HEALTHCARE SYSTEM · Nov 18, 2022

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of managing pain for patients undergoing surgery for esophageal cancer. The standard method, called thoracic epidural analgesia (TEA), uses a continuous flow of medicine to numb the area, but it can sometimes cause serious side effects. The trial is exploring a newer method called Erector Spinae analgesia (ESP), which might provide similar pain relief with fewer side effects. The researchers will compare these two methods in a group of 50 patients who are having thoracolaparoscopic esophagectomies, a type of surgery to remove part of the esophagus.

To be eligible for this trial, participants must be diagnosed with esophageal cancer and scheduled for the surgery. They should also be able to give informed consent. However, individuals who refuse to participate, have allergies to local anesthetics, or certain health conditions may not be able to join. Throughout the study, participants will receive either TEA or ESP for pain control after their surgery, and the researchers will monitor their pain levels and any additional medical needs for three days following the procedure. This study aims to find out if ESP can be a safe and effective alternative to TEA for managing pain after esophageal surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are diagnosed with esophageal cancer and scheduled to for TLE using Akiyama technique,
• • Informed and signed the consent
• Exclusion Criteria:
• • patient refusal,
• • allergy to local anesthetic (LA),
• • complex congenital malformation,
• • mental deficit,
• • substance abuse (alcohol, opioids, etc.)
• • renal insufficiency